← Back to list
Upcoming Policies effective December 1, 2026
Act
by Nov 15, 2026
Effective date
Dec 1, 2026
Identified
Oct 2, 2026
Summary
Blue Cross Minnesota is inactivating 12 medical policies effective December 1, 2026, primarily affecting laboratory testing, genetic screening, and diagnostic panels (Barrett's Esophagus surveillance, cardiovascular risk biomarkers, substance use drug testing, cancer genetic panels, vitamin D screening, and others). The billing team must identify all claims currently billed under these policy numbers and determine replacement coverage guidance or discontinue billing for these services.
Get alerts when payers change rules like this one
We check Blue Cross and Blue Shield of Minnesota and other payers every day and email you when a change matches your specialty and state.
Get Blue Cross and Blue Shield of Minnesota alertsPolicy Monitoring is free. No card required.
What to do
by Nov 15, 2026 · 6 steps
01Billing team must obtain replacement policy guidance from Blue Cross Minnesota for the 12 inactivated policies (VI-61, VI-24, VI-47, VI-51, VI-59, VI-56, VI-16, VI-09, VI-30, VI-55, VI-32, VI-60).
02For each inactivated policy, determine: (1) whether coverage continues under a new policy number, (2) whether the service becomes non-covered, or (3) whether alternative billing guidance applies.
03Update billing system edits, prior authorization rules, and encounter templates accordingly.
04Providers must be notified of any changes to commonly ordered tests (genetic panels, drug testing, vitamin D screening, cardiovascular biomarkers).
05After December 1, 2026, do not bill claims referencing the inactivated policy numbers.
06Claims submitted with invalid policy references will be denied or returned for correction.
Original notice
Upcoming Policies effective December 1, 2026
bluecrossmn.widen.net · Always check the source before changing claims.